FrancophonIA/ELRC3.0 huggingface dataset:
English: MIRAPEXIN can reduce the production of breast milk.
Croatian: MIRAPEXIN može smanjiti stvaranje majčinog mlijeka.
English: Within the system organ classes, adverse reactions are listed under headings of frequency (number of patients expected to experience the reaction), using the following categories: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000); not known (cannot be estimated from the available data)..
Croatian: U klasifikaciji prema organskim sustavima, nuspojave su navedene prema učestalosti (broj bolesnika kod kojih se očekuje nuspojava), uz uporabu sljedećih kategorija: vrlo često (≥1/10); često (≥1/100 do <1/10); manje često (≥1/1000 do <1/100); rijetko (≥1/10 000 do <1/1000); vrlo rijetko (<1/10 000); nepoznato (ne može se procijeniti iz dostupnih podataka).
English: What MIRAPEXIN is and what it is used for
Croatian: Što je MIRAPEXIN i za što se koristi
English: Each blister strip contains 10 tablets.
Croatian: Svaki blister sadrži 10 tableta.
English: Therefore, do not take MIRAPEXIN if you are pregnant unless your doctor tells you to do so.
Croatian: Stoga, ne uzimajte MIRAPEXIN tijekom trudnoće, osim ako Vam to ne preporuči liječnik.
English: With 95 % certainty, the frequency category is not greater than uncommon, but might be lower.
Croatian: Sa sigurnošću od 95%, kategorija učestalosti nije veća od „manje često“, ali može biti niža.
English: You can take MIRAPEXIN with or without food.
Croatian: Možete uzimati MIRAPEXIN sa ili bez hrane.
English: A sudden stop could cause you to develop a medical condition called neuroleptic malignant syndrome which may represent a major health risk.
Croatian: Iznenadan prekid može dovesti do razvoja medicinskog stanja koje se naziva maligni neuroleptički sindrom, koji može predstavljati velik rizik za zdravlje.
English: The daily dose is administered in equally divided doses 3 times a day.
Croatian: Ukupna dnevna doza primjenjuje se u ravnomjerno podijeljenim dozama 3 puta dnevno.
English: The tablets should be taken orally, swallowed with water, and can be taken either with or without food.
Croatian: Tablete se uzimaju peroralno, gutaju se s vodom, te se mogu uzimati sa ili bez hrane.
English: Out of these, approximately 1,000 were in more advanced stages, received concomitant levodopa therapy, and suffered from motor complications.
Croatian: Njih oko 1000 bili su u uznapredovalim stadijima bolesti, istovremeno su dobivali terapiju levodopom, te su imali motoričke komplikacije.
English: Augmentation was observed in 11.8% of patients in the pramipexole group (N = 152) and 9.4% of patients in the placebo group (N = 149).
Croatian: Augmentacija je primijećena kod 11,8% bolesnika u skupini na pramipeksolu (N=152) i 9,4% bolesnika u skupini na placebu (N=149).
English: This includes medicines, herbal remedies, health foods or supplements that you have obtained without a prescription.
Croatian: To uključuje lijekove, biljne pripravke, zdravu hranu ili dodatke prehrani koje ste nabavili bez recepta.
English: The elimination half-life (t½) varies from 8 hours in the young to 12 hours in the elderly.
Croatian: 1/2) varira od 8 sati kod mladih sve do 12 sati kod starijih osoba.
English: Efficacy was maintained in 87 of 103 patients switched to MIRAPEXIN prolonged-release tablets.
Croatian: Djelotvornost je održana kod 87 od 103 bolesnika koji su prešli na MIRAPEXIN tablete s produljenim oslobađanjem.
English: Concomitant administration with food does generally not affect the bioavailability of pramipexole.
Croatian: Istovremena primjena s hranom općenito ne utječe na bioraspoloživost pramipeksola.
English: Rare: - Mania (agitation, feeling elated or over-excited)
Croatian: Rijetko: - manija (uznemirenost, osjećaj ushita ili pretjeranog uzbuđenja)
English: Then take your MIRAPEXIN prolonged-release tablets next morning and do not take any more MIRAPEXIN (immediate release) tablets.
Croatian: Zatim uzmite MIRAPEXIN tablete s produljenim oslobađanjem sljedeće jutro i ne uzimajte više MIRAPEXIN tablete (s trenutnim oslobađanjem).
English: What MIRAPEXIN is and what it is used for What you need to know before you take MIRAPEXIN How to take MIRAPEXIN
Croatian: Što je MIRAPEXIN i za što se koristi Što morate znati prije nego počnete uzimati MIRAPEXIN Kako uzimati MIRAPEXIN
English: Other medicines and MIRAPEXIN
Croatian: Drugi lijekovi i MIRAPEXIN
English: Although dystonia may be a symptom of Parkinson's disease, the symptoms in these patients have improved after reduction or withdrawal of pramipexole.
Croatian: Iako distonija može biti simptom Parkinsonove bolesti, simptomi u tih bolesnika poboljšali su se nakon smanjenja doze ili povlačenja pramipeksola.
English: - Altered or increased sexual interest and behaviour of significant concern to you or to others,
Croatian: - promijenjeno ili povećano zanimanje za seks i ponašanje koje znatno zabrinjava Vas ili druge, na primjer, povećani spolni nagon.*
English: If affected, do not drive or use machines.
Croatian: Ukoliko se to dogodi, ne upravljajte vozilima ili strojevima.
English: If you suffer from Parkinson's disease, you may experience the following side effects:
Croatian: Ako patite od Parkinsonove bolesti, moguće su sljedeće nuspojave:
English: In a placebo-controlled polysomnography study over 3 weeks MIRAPEXIN significantly reduced the number of periodic limb movements during time in bed.
Croatian: U placebom kontroliranom polisomnografskom ispitivanju, u trajanju preko 3 tjedna, MIRAPEXIN je znatno smanjio broj periodičnih pokreta udovima tijekom vremena provedenog u krevetu.
English: Intake of a high fat meal induced an increase in peak concentration (Cmax) of about 24% after a single dose administration and about 20% after multiple dose administrations and a delay of about 2 hours in time to reach peak concentration in healthy volunteers.
Croatian: Unos obroka s visokim udjelom masnoća potaknuo je porast vršnih koncentracija (Cmax) od oko 24% nakon jednokratne primjene i oko 20% nakon višestruke primjene doze te odgodu od oko 2 sata u postizanju vršne koncentracije kod zdravih dobrovoljaca.
English: Nausea and fatigue were more often reported in female patients treated with MIRAPEXIN (20.8% and 10.5%, respectively) compared to males (6.7% and 7.3%, respectively).
Croatian: Mučnina i umor češće su prijavljeni kod žena liječenih MIRAPEXINOM (20,8% i 10,5%, po istom redoslijedu) u usporedbi s muškarcima (6,7% i 7,3%, po istom redoslijedu).
English: Tablets are scored on both sides and breakable in halves.
Croatian: Tablete imaju razdjelnu crtu na obje strane i mogu se prepoloviti.
English: - You may experience vomiting, restlessness, or any of the side effects as described in section 4 “Possible side effects”.
Croatian: - Mogu se javiti povraćanje, nemir, ili neka od nuspojava koje su opisane u dijelu 4. „Moguće nuspojave“.
English: However, the potential influence of hepatic insufficiency on MIRAPEXIN pharmacokinetics has not been investigated.
Croatian: Međutim, potrebno je znati da potencijalni utjecaj insuficijencije jetre na farmakokinetiku MIRAPEXINA nije istraživan.
English: If you forget to take a dose of MIRAPEXIN, but remember within 12 hours of your usual time, take your tablet straightaway and then take your next tablet at the usual time.
Croatian: Ako ste zaboravili uzeti dozu MIRAPEXINA te se sjetite u roku 12 sati od uobičajenog vremena doziranja, uzmite tabletu odmah, a zatim uzmite sljedeću tabletu u uobičajeno vrijeme.
English: Do not stop taking MIRAPEXIN without first talking to your doctor.
Croatian: Ne prekidajte uzimanje MIRAPEXINA bez prethodnog razgovora s liječnikom.
English: MIRAPEXIN can be taken with or without food.
Croatian: MIRAPEXIN se može uzimati sa ili bez hrane.
English: Do not chew, divide or crush the prolongedrelease tablets.
Croatian: Ne žvačite, dijelite, ili drobite tablete s produljenim oslobađanjem.
English: MIRAPEXIN contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain.
Croatian: MIRAPEXIN sadrži djelatnu tvar pramipeksol i pripada skupini lijekova poznatih kao agonisti dopamina koji stimuliraju dopaminergičke receptore u mozgu.
English: Tell your doctor if you experience symptoms such as depression, apathy, anxiety, fatigue, sweating or pain after stopping or reducing your MIRAPEXIN treatment.
Croatian: Obavijestite svog liječnika ako osjetite simptome poput depresije, apatije, tjeskobe, umora, znojenja ili boli nakon prestanka liječenja ili sniženja doze MIRAPEXINA.
English: In humans, the protein binding of pramipexole is very low (< 20%) and the volume of distribution is large (400 l).
Croatian: U ljudi, vezanje pramipeksola na proteine plazme je vrlo nisko (<20%), a volumen distribucije je vrlo velik (400 l).
English: The following dose schedule is suggested for initiation of therapy:
Croatian: Preporučuje se sljedeća shema doziranja u početku liječenja:
English: Talk to your doctor before taking MIRAPEXIN.
Croatian: Obratite se svom liječniku prije nego uzmete MIRAPEXIN.
English: The use of MIRAPEXIN tablets should be considered.
Croatian: Potrebno je razmotriti primjenu MIRAPEXIN tableta.
English: PHARMACEUTICAL FORM AND CONTENTS 10 prolonged-release tablets 30 prolonged-release tablets 100 prolonged-release tablets
Croatian: OBLIK I SADRŽAJ 10 tableta s produljenim oslobađanjem 30 tableta s produljenim oslobađanjem 100 tableta s produljenim oslobađanjem
English: In half of the 16 patients who did not meet the criterion for maintained efficacy on UPDRS Part II+III score, the change from baseline was considered not clinically relevant.
Croatian: Kod polovine od 16 bolesnika koji nisu udovoljili kriteriju za održavanje djelotvornosti prema rezultatu na UPDRS ljestvici, dijelovima II+III, promjena u odnosu na početnu vrijednost ne smatra se klinički značajnom.
English: A decreased body weight by 30 kg results in an increase in
Croatian: Smanjena tjelesna težina za 30 kg rezultira porastom Cmax od 45%.
English: Rottendorf Pharma GmbH Ostenfelder Strasse 51 - 61 59320 Ennigerloh Germany
Croatian: Rottendorf Pharma GmbH Ostenfelder Strasse 51 - 61 59320 Ennigerloh Njemačka
English: However, in Phase III trials in Parkinson's disease patients no clinically meaningful influence of body weight on the therapeutic effect and tolerability of MIRAPEXIN prolonged-release tablets was detected.
Croatian: Međutim, u fazi III kliničkog ispitivanja na bolesnicima s Parkinsonovom bolešću nije pronađen klinički značajan utjecaj tjelesne težine na terapijski učinak i podnošljivost MIRAPEXIN tableta s produljenim oslobađanjem.
English: Therefore, medicinal products that are inhibitors of this active renal elimination pathway or are eliminated by this pathway, such as cimetidine, amantadine, mexiletine, zidovudine, cisplatin, quinine, and procainamide, may interact with pramipexole resulting in reduced clearance of pramipexole.
Croatian: Stoga, lijekovi koji su inhibitori tog aktivnog renalnog puta eliminacije ili se tim putem odstranjuju, kao što su cimetidin, amantadin i meksiletin, zidovudin, cisplatin, kinin i prokainamid, mogu stupiti u interakciju s pramipeksolom, što može rezultirati smanjenim klirensom pramipeksola.
English: 6.5 Nature and contents of container OPA/aluminium/PVC-aluminium blisters.
Croatian: 6.5 Vrsta i sadržaj spremnika OPA/aluminij/PVC-aluminijski blisteri.
English: There is no clinical experience with massive overdose.
Croatian: Za sada nema kliničkih iskustava snažnog predoziranja.
English: Pramipexole alleviates parkinsonian motor deficits by stimulation of dopamine receptors in the striatum.
Croatian: Pramipeksol reducira parkinsonske motorne deficite, stimulirajući dopaminske receptore u strijatumu.
English: EXPIRY DATE EXP {MM/YYYY}
Croatian: ROK VALJANOSTI EXP {MM/GGGG}
English: If use of MIRAPEXIN is unavoidable, breast-feeding should be stopped.
Croatian: Ako je primjena MIRAPEXINA neizbježna, potrebno je prekinuti dojenje.
English: If renal function declines during maintenance therapy the MIRAPEXIN daily dose should be reduced by the same percentage as the decline in creatinine clearance, i.e. if creatinine clearance declines by 30%, then the MIRAPEXIN daily dose should be reduced by 30%.
Croatian: Ukoliko dođe do pogoršanja funkcije bubrega za vrijeme terapije održavanja, dnevnu dozu MIRAPEXINA je potrebno sniziti u istom postotku za koji se smanjio klirens kreatinina, tj. ako se klirens smanjio za 30%, tada je potrebno sniziti ukupnu dnevnu dozu MIRAPEXINA za 30%.
English: In a clinical trial with healthy volunteers, where MIRAPEXIN prolonged-release tablets were titrated faster (every 3 days) than recommended up to 3.15 mg pramipexole base (4.5 mg of salt) per day, an increase in blood pressure and heart rate was observed.
Croatian: U kliničkom ispitivanju na zdravim dobrovoljcima, gdje su MIRAPEXIN tablete s produljenim oslobađanjem brže titrirane (svaka 3 dana) nego što je preporučeno do 3,15 mg baze pramipeksola (4,5 mg soli) dnevno, primijećeni su porast krvnog tlaka i srčane frekvencije.
English: The daily dose can be administered in two divided doses if creatinine clearance is between 20 and 50 ml/min and as a single daily dose if creatinine clearance is less than 20 ml/min.
Croatian: Ukupna dnevna doza može se primjenjivati u dvije odvojene doze ako je klirens kreatinina u rasponu od 20 i 50 ml/min, te u jednoj dnevnoj dozi ako je klirens kreatinina manji od 20 ml/min.
English: Patients being treated with MIRAPEXIN and presenting with somnolence and/or sudden sleep episodes must be informed to refrain from driving or engaging in activities where impaired alertness may put themselves or others at risk of serious injury or death (e.g. operating machines) until such recurrent episodes and somnolence have resolved (see also sections 4.4, 4.5 and 4.8).
Croatian: Bolesnike koji su tijekom liječenja MIRAPEXINOM imali somnolenciju i/ili epizode iznenadnog usnivanja potrebno je upozoriti da ne upravljaju motornim vozilima ili obavljaju nekakve druge aktivnosti gdje bi njihova smanjena mogućnost reagiranja ponekad mogla ugroziti vlastitu ili tuđu sigurnost te dovesti do rizika za tešku ozljedu ili smrt (npr. upravljanje strojevima), sve dok takve opetovane epizode i somnolencija ne prestanu (vidjeti također dijelove 4.4, 4.5 i 4.8).
English: - Dystonia (inability of keeping your body and neck straight and upright (axial dystonia)).
Croatian: - Distonija (nemogućnost držanja tijela i vrata ravno i uspravno (aksijalna distonija)).
English: In a cross-sectional, retrospective screening and case-control study including 3,090 Parkinson's disease patients, 13.6% of all patients receiving dopaminergic or non-dopaminergic treatment had symptoms of an impulse control disorder during the past six months.
Croatian: U presječnom, retrospektivnom „screening“ i slučaj-kontrola ispitivanju, koje je uključivalo 3090 bolesnika s Parkinsonovom bolešću, 13,6% svih bolesnika koji su primali dopaminergičko ili nedopaminergičko liječenje imalo je simptome poremećaja kontrole nagona tijekom proteklih šest mjeseci.
English: Axial dystonia including antecollis, camptocormia and pleurothotonus (Pisa Syndrome) has occasionally been reported in patients with Parkinson's disease following initiation or incremental dose increase of pramipexole.
Croatian: Aksijalna distonija, uključujući antekolis, kamptokormiju i pleurototonus (Pisa sindrom), povremeno je zabilježena u bolesnika s Parkinsonovom bolešću nakon početka liječenja ili postupnog povećanja doze pramipeksola.
English: Tell your doctor if you have (had) or develop any medical conditions or symptoms, especially any of the following: - Kidney disease - Hallucinations (seeing, hearing or feeling things that are not there).
Croatian: Obavijestite liječnika ako imate (ili ste imali) ili razvijete medicinska stanja ili simptome, osobito sljedeće: - Bolesti bubrega - Halucinacije (vidite, čujete ili osjećate stvari koje nisu prisutne).
English: High brain tissue concentrations were observed in the rat (approx. 8-fold compared to plasma).
Croatian: Visoke koncentracije u moždanom tkivu primijećene su kod štakora (oko 8 puta u usporedbi s plazmatskim).
English: In the absence of human data, MIRAPEXIN should not be used during breast-feeding.
Croatian: U nedostatku podataka za ljude, MIRAPEXIN se ne bi trebao primjenjivati tijekom dojenja.
English: If you suffer from Parkinson's disease you should not stop treatment with MIRAPEXIN abruptly.
Croatian: Ako patite od Parkinsonove bolesti, ne smijete naglo prekidati liječenje MIRAPEXINOM.
English: Pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with dopamine agonists including MIRAPEXIN (see section 4.4).
Croatian: Patološka želja za kockanjem, pojačani libido, hiperseksualnost, kompulzivno trošenje ili kupovanje, prejedanje i kompulzivno jedenje se mogu pojaviti kod bolesnika koji se liječe agonistom dopamina, uključujući MIRAPEXIN (vidjeti dio 4.4).
English: In the Phase III studies that established safety and efficacy of MIRAPEXIN prolonged-release tablets, patients were instructed to take study medication without regard to food intake.
Croatian: U ispitivanjima faze III, koja su utvrđivala sigurnost i djelotvornost MIRAPEXIN tableta s produljenim oslobađanjem, bolesnici su bili upućeni na uzimanje lijeka iz ispitivanja, bez obzira na unos hrane.
English: - Dyskinesia (e.g. abnormal, uncontrolled movements of the limbs).
Croatian: - Diskinezija (npr. abnormalni, nekontrolirani pokreti udova).
English: What you need to know before you take MIRAPEXIN
Croatian: Što morate znati prije nego počnete uzimati MIRAPEXIN
English: Decreases in diastolic and systolic pressure and heart rate were noted in the minipig, and a tendency to a hypotensive effect was discerned in the monkey.
Croatian: Smanjenje dijastoličkog i sistoličkog tlaka i broja otkucaja srca uočeno je kod patuljastih svinja, kao i sklonost k hipotenzivnom učinku kod majmuna.
English: The treatment of patients with a creatinine clearance below 30 ml/min with MIRAPEXIN prolongedrelease tablets is not recommended as no data are available for this patient population.
Croatian: Kod bolesnika s klirensom kreatinina manjim od 30 ml/min, ne preporučuje se liječenje MIRAPEXIN tabletama s produljenim oslobađanjem, s obzirom da nisu dostupni podaci za ovu skupinu bolesnika.
English: Other significant adverse events leading to discontinuation of study medication for patients receiving pramipexole were confusional state, speech disorder and aggravated condition (see section 4.2).
Croatian: Druge značajne nuspojave, za bolesnike na pramipeksolu, koje su dovele do prekida uzimanja ispitivanog lijeka bile su konfuzno stanje, poremećaj govora i pogoršanje stanja (vidjeti dio 4.2).
English: Endocrine disorders inappropriate antidiuretic hormone secretion
Croatian: Endokrini poremećaji neodgovarajuće izlučivanje antidiuretskog hormona
English: MIRAPEXIN is indicated in adults for treatment of the signs and symptoms of idiopathic Parkinson's disease, alone (without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or “on off” fluctuations).
Croatian: MIRAPEXIN je indiciran za liječenje znakova i simptoma idiopatske Parkinsonove bolesti u odraslih, u obliku monoterapije (bez levodope) ili u kombinaciji s levodopom, tj. tijekom trajanja bolesti, pa sve do uznapredovale faze, kada učinak levodope jenjava ili postane nestalan te dolazi do fluktuacija u terapijskom učinku (učinak "kraja doze” ili “on-off” fluktuacije).
English: Take MIRAPEXIN prolonged-release tablets only once a day and each day at about the same time.
Croatian: Uzimajte MIRAPEXIN tablete s produljenim oslobađanjem jedanput dnevno i to svaki dan u otprilike isto vrijeme.
English: Patients already taking MIRAPEXIN tablets may be switched to MIRAPEXIN prolonged-release tablets overnight, at the same daily dose.
Croatian: Bolesnici koji već uzimaju MIRAPEXIN tablete mogu se prebaciti na MIRAPEXIN tablete s produljenim oslobađanjem tijekom noći, u jednakoj dnevnoj dozi.
English: - Sleepiness and episodes of suddenly falling asleep - Psychosis (e.g. comparable with symptoms of schizophrenia) - Vision impairment.
Croatian: - Pospanost i epizode iznenadnog usnivanja - Psihoza (npr. usporedivo sa simptomima shizofrenije) - Oštećenje vida.
English: The safety and efficacy of MIRAPEXIN prolonged-release tablets in the treatment of Parkinson's disease was evaluated in a multinational drug development program consisting of three randomised, controlled trials.
Croatian: Sigurnost i djelotvornost MIRAPEXIN tableta s produljenim oslobađanjem u liječenju Parkinsonove bolesti ocjenjivane su u multinacionalnom razvojnom programu lijeka, koji se sastojao od tri randomizirana kontrolirana ispitivanja.
English: What MIRAPEXIN contains
Croatian: Što MIRAPEXIN sadrži
English: Each blister strip contains 10 prolonged-release tablets.
Croatian: Svaki blister sadrži 10 tableta s produljenim oslobađanjem.
English: If you take more MIRAPEXIN than you should If you accidentally take too many tablets, - Contact your doctor or nearest hospital casualty department immediately for advice.
Croatian: Ako slučajno uzmete previše tableta, - Odmah se javite liječniku ili na odjel najbliže bolnice za savjet.
English: The maximum plasma concentrations occur at about 6 hours after administration of MIRAPEXIN prolonged-release tablets once daily.
Croatian: Maksimalne koncentracije u plazmi se javljaju oko 6 sati nakon primjene MIRAPEXIN tableta s produljenim oslobađanjem jedanput dnevno.
English: After switching to MIRAPEXIN prolonged-release tablets, the dose may be adjusted depending on the patient's therapeutic response (see section 5.1).
Croatian: Nakon prijelaza na MIRAPEXIN tablete s produljenim oslobađanjem, doza se može podesiti prema terapijskom odgovoru bolesnika (vidjeti dio 5.1).
English: MIRAPEXIN is indicated in adults for symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in doses up to 0.54 mg of base (0.75 mg of salt) (see section 4.2).
Croatian: MIRAPEXIN je indiciran za simptomatsko liječenje umjerenog do teškog idiopatskog sindroma nemirnih nogu u odraslih pri dozama do 0,54 mg baze (0,75 mg soli) (vidjeti dio 4.2).
English: BATCH NUMBER Lot {number}
Croatian: BROJ SERIJE Lot {broj}
English: The other ingredients are hypromellose 2208, maize starch, carbomer 941, colloidal anhydrous silica, magnesium stearate.
Croatian: Drugi sastojci su hipromeloza 2208, kukuruzni škrob, karbomer 941, bezvodni koloidni silicijev dioksid, magnezijev stearat.
English: Not known: - After stopping or reducing your MIRAPEXIN treatment: Depression, apathy, anxiety, fatigue,
Croatian: Nepoznato: - Nakon prestanka liječenja ili sniženja doze lijeka MIRAPEXIN: mogu se javiti depresija, apatija,
English: When the intake of a dose is missed, MIRAPEXIN prolonged-release tablets should be taken within 12 hours after the regularly scheduled time.
Croatian: Kada se propusti doziranje, MIRAPEXIN tablete s produljenim oslobađanjem se uzimaju u roku 12 sati nakon redovnog vremena doziranja.
English: MIRAPEXIN prolonged-release tablets were non-inferior to pramipexole immediate release tablets as assessed on the UPDRS Parts II+III score at week 33.
Croatian: MIRAPEXIN tablete s produljenim oslobađanjem nisu bile inferiorne pramipeksol tabletama s trenutnim oslobađanjem, ocjenjivano prema rezultatu UPDRS-ljestvice-dijelovima II+III nakon 33 tjedna.
English: Very common: - Nausea (sickness)
Croatian: Vrlo često: - mučnina
English: You should avoid taking MIRAPEXIN together with antipsychotic medicines.
Croatian: Potrebno je izbjegavati istovremenu primjenu MIRAPEXINA i antipsihotičnih lijekova.
English: In patients pramipexole alleviates signs and symptoms of idiopathic Parkinson's disease.
Croatian: U bolesnika, pramipeksol otklanja znakove i simptome idiopatske Parkinsonove bolesti.